Shanghai company approved to mass produce A/H1N1 flu vaccine

Ma Xianghu, head of bio-product center under the Shanghai Institute of Biological Sciences, told Xinhua Wednesday that the city-made vaccine adopted state-of-the-art ether technique, with less residue and weak clinical side-effect.

 Prior to the National Day on Oct. 1, the institute will produce 3 million bottles of A/H1N1 flu vaccine, and its output will reach 10 million bottles at the end of the year, according to Ma.

On Tuesday night, officials with the institute met the Ministry of Industry and Information Technology, which is in charge of vaccine production and storage, to discuss production plans, according to Wednesday's Shanghai Daily.

The free vaccine, with purchase price covered by the government, is for people aged over three and one shot is reportedly enough to protecting against the A/H1N1 flu virus; Kazinform has learn from China View.

Read full story at www.chinaview.cn